< Back to companies
Aummune (אומיון)

Aummune (אומיון)

Tel Aviv-Yafo, Israel

Aummune creates individualized therapeutics designed to specifically target each stage of a patient's disease. The company's platform addresses the need for safe, highly personalized, agile targeted therapies for cancer, antibiotic-resistant bacteria, and viruses. Ammune is currently a part of the aMoon Fund, an Israeli VC.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2017
Website
aummune.com/

Categories

Cancer
Only accessible to MedStartr community members. Join now

What do you think of Aummune (אומיון)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now